Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HTBX - Heat Biologics COVID-19 vaccine shows encouraging action in preclinical study


HTBX - Heat Biologics COVID-19 vaccine shows encouraging action in preclinical study

  • Heat Biologics (NASDAQ:HTBX) announces results from preclinical testing of its COVID-19 vaccine candidate that, it says, showed immunogenicity in animal models including expansion of human-HLA-restricted T cells against immunodominant epitopes of SARS-CoV-2 spike protein, adding that the results also showed expansion of antibody-supporting CD4+ and virus-killing CD8+ T cells in the lungs of mice.
  • More news on: Heat Biologics, Inc., Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Heat Biologics Inc.
Stock Symbol: HTBX
Market: NASDAQ
Website: heatbio.com

Menu

HTBX HTBX Quote HTBX Short HTBX News HTBX Articles HTBX Message Board
Get HTBX Alerts

News, Short Squeeze, Breakout and More Instantly...